Initial therapy for patients with chronic lymphocytic leukemia

Seminars in Oncology
William G Wierda, Susan M O'Brien

Abstract

Evolution of frontline treatment for patients with chronic lymphocytic leukemia (CLL) has been driven by the objective of increasing complete remission (CR) rates and achieving maximum elimination of leukemia. As a result, effective combination regimens incorporating new agents such as monoclonal antibodies have been developed. Beyond morphologic CR, evaluation for residual disease by multicolor flow cytometry or molecular techniques may provide a tool to assess potentially more effective therapies. Although new prognostic factors correlate with time to treatment and survival have been identified, the utility of these factors in predicting response rates or response duration has not been established. Clearly, strides have been made in developing effective treatments that are improving remission duration with the ultimate goal of improving survival for patients with CLL. Herein, we review the recent progress in frontline therapies for patients with CLL.

Citations

Oct 20, 2006·Cancer Immunology, Immunotherapy : CII·Amal MansourElizabeth Raveche
Jun 30, 2009·Journal of Immunotherapy·James N KochenderferSteven A Rosenberg
Apr 19, 2011·Blood·William G WierdaUNKNOWN 407 Study Investigators
Mar 16, 2013·OncoTargets and Therapy·Osmond J D'Cruz, Fatih M Uckun
Feb 27, 2008·International Reviews of Immunology·Fatih M Uckun
Jun 17, 2009·Expert Opinion on Pharmacotherapy·David Masiello, Anil Tulpule
Oct 26, 2006·British Journal of Haematology·Fatih M UckunSanjive Qazi
May 3, 2007·Clinical Journal of Oncology Nursing·Kimberly Noonan
Dec 8, 2007·Clinical Journal of Oncology Nursing·Mollie MoranEmma Buckby
Jan 21, 2010·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Kaci Wilhelm, Daisy Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.